Background: Acinetobacter baumannii is undoubtedly one of the most clinically important
pathogens causing nosocomial infections worldwide. It is difficult to control, and the …

This study investigated the clinical epidemiology and resistance mechanisms of
Acinetobacter baumannii and characterised the clonal diversity of carbapenem-resistant A …

Acinetobacter baumannii has emerged as a problematic multidrug-resistant (MDR)
pathogen worldwide. The aim of this study was to characterize clinical isolates of A …

Abstract Objectives Carbapenem-resistant Acinetobacter baumannii (CRAB) has become a
worldwide issue. This study aimed to characterise the epidemiology and genetic …

Background Carbapenem-resistant Acinetobacter baumannii has emerged as an important
cause of nosocomial infections with high morbidity and mortality. The carbapenemases …

Carbapenem-resistant Acinetobacter baumannii is a major health problem worldwide,
especially in intensive care units (ICUs). This study aimed to detect the prevalence of A …

Background: The prevalence of carbapenem resistance in Acinetobacter baumannii has
been increasing worldwide, and therapeutic options are extremely limited. We performed a …

Acinetobacter baumannii is a common cause of healthcare-associated infections (HAI)
worldwide, mostly occurring in intensive care units (ICUs). Extended-spectrum beta …

The worldwide distribution of carbapenem-resistant Acinetobacter baumannii (CRAB) has
become a global concern, particularly in countries where antibiotic prescription is not tightly …

The emergence of Carbapenem-resistant Acinetobacter baumannii is a threat to modern
medicine and has been recognised globally. Epidemic clones of A. baumannii are …